Treatment of the 2 to 3 cm renal mass

Journal of Urology

Volumn 184, Issue 2, 2010, Pages 419-422

  Aron, Monish ^a   Gill, Inderbir S ^a   Boorjian, Stephen A ^b   Uzzo, Robert G ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SURGERY; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CRYOABLATION; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE SEVERITY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; KIDNEY CANCER; KIDNEY CARCINOMA; KIDNEY METASTASIS; KIDNEY TUMOR; MORBIDITY; NEEDLE BIOPSY; NEPHRON SPARING SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; REVIEW; SALVAGE THERAPY; SENSITIVITY AND SPECIFICITY; SMALL RENAL MASS; SURGICAL TECHNIQUE; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 77955466550     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.05.050     Document Type: Note

References (18)

1. I.S. Gill, M. Aron, and D.A. Gervais Clinical practice Small renal mass N Engl J Med 362 2010 624
2. S.N. Chawla, P.L. Crispen, and A.L. Hanlon The natural history of observed enhancing renal masses: meta-analysis and review of the world literature J Urol 175 2006 425
3. M.M. Nguyen, and I.S. Gill Effect of renal cancer tumor size on the prevalence of metastasis at diagnosis and mortality J Urol 181 2009 1020
4. P.L. Crispen, Y.-N. Wong, and R.E. Greenberg Predicting growth of solid renal masses under active surveillance Urol Oncol Semin 26 2008 555
5. I. Frank, M.L. Blute, and J.C. Cheville Solid renal tumors: an analysis of pathological features related to tumor size J Urol 170 2003 2217
6. D.A. Kunkle, P.L. Crispen, and T. Li Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses J Urol 177 2007 1692
7. D.A. Kunkle, P.L. Crispen, and D.Y.T. Chen Enhancing renal masses with zero net growth during active surveillance J Urol 177 2007 849
8. P.L. Crispen, R. Viterbo, and S.A. Boorjian Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active aurveillance Cancer 115 2009 2844
9. F.J. Rybicki, K.M. Shu, and E.S. Cibas Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses AJR Am J Roentgenol 180 2003 1281
10. I.S. Gill, K. Kamoi, and M. Aron 800 Laparoscopic partial nephrectomies: a single surgeon series J Urol 183 2010 34
11. M. Aron, K. Kamoi, and E. Remer Laparoscopic renal cryoablation: 8-year, single surgeon outcomes J Urol 183 2010 889
12. J.M. Hollingsworth, D.C. Miller, and S. Daignault Rising incidence of small renal masses: a need to reassess treatment effect J Natl Cancer Inst 98 2006 1331
13. D.A. Kunkle, B.L. Egleston, and R.G. Uzzo Excise, ablate, or observe: the small renal mass dilemma-a meta-analysis and review J Urol 179 2008 1227
14. B.R. Lane, D. Babineau, and M.W. Kattan A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy J Urol 178 2007 429
15. J. Rothman, B. Egleston, and Y.N. Wong Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis J Urol 181 2009 29
16. M.A. Jewett, and A. Zuniga Renal tumor natural history: the rationale and role for active surveillance Urol Clin North Am 35 2008 627
17. P.L. Crispen, R. Viterbo, and E.B. Fox Delayed intervention of sporadic renal masses under active surveillance Cancer 112 2008 1051
18. A. Kutikov, B.L. Egleston, and Y.N. Wong Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram J Clin Oncol 28 2009 311